Product
JZP385
1 clinical trial
1 indication
Indication
Essential TremorClinical trial
A Phase 2b, 12-week, Double-blind, Placebo-controlled, Randomized, Parallel Group, Multicenter Study of the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential TremorStatus: Active (not recruiting), Estimated PCD: 2024-05-31